Teams Explore Epigenetic Consequences of Mutating Cancer-Associated Enzyme | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A trio of new studies in Nature are highlighting the ties between genetic mutations and epigenetic alterations in cancer — particularly the genome-wide methylation and transcriptional changes associated with mutations to the IDH1, a gene coding for the metabolic enzyme isocitrate dehydrogenase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."